Treatment for COPD with Cells

The Role of Cells

Cells are essential building block for survival. Cells are responsible for being the foundation for every living being. They are capable of forming any tissue or organ in the body, which is unique from other cells, while they can still self-renew and replicate constantly.

How Cells Can Be Used as a COPD Treatment

Cellular therapy at the Lung Institute has proven to improve the function of the lungs affected by chronic lung disease, but cells are capable of forming any differentiated cell, so they can actually develop into any organ or tissue in the body, which proves their versatility in the medical field. Since cells self-renew, they divide indefinitely, which means they are ideal for the promotion of healing of of damaged organs. As new tissue is created by the cells, organs are strengthened and the effects of organ damage are minimized.

Types of Treatments for COPD with Cells

The Lung Institute, with locations in Florida, Tennessee, Arizona, and Pennsylvania, offers COPD treatments with autologous cells. The cells come directly from an adult patient’s body only to be administered to the same patient. This decreases the potential of rejection and undermines any possible controversy about cellular therapy.

The Lung Institute provides a blood-derived treatment.  During cellular therapy, the cells target the damaged tissue or organ in order to reinforce function and improve lives.

The Treatment Process

Depending on the therapy recommended, the cells are then extracted from the patient’s body through blood. The cells are isolated by a professional, and almost immediately, the cells are given back to the individual intravenously. Now, the cells can begin to help promote healing in the damaged lung tissue, so patients can breathe easier and bring their life within reach.

If you or a loved one want to learn more about which treatments for COPD may help you battle lung disease and improve your life, contact us or call us at (800) 729-3065.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.